Anti-inflammatory Role of Mesenchymal Stem Cells in an Acute Lung Injury Mouse Model
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Mesenchymal stem cells (MSCs) attenuate injury in various lung injury models through paracrine effects. We hypothesized that intratracheal transplantation of allogenic MSCs could attenuate lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice, mediated by anti-inflammatory responses. Methods: Six-week-old male mice were randomized to either the control or the ALI group. ALI was induced by intratracheal LPS instillation. Four hours after LPS instillation, MSCs or phosphate-buffered saline was randomly intratracheally administered. Neutrophil count and protein concentration in bronchoalveolar lavage fluid (BALF); lung histology; levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and macrophage inflammatory protein-2; and the expression of proliferation cell nuclear antigen (PCNA), caspase-3, and caspase-9 were evaluated at 48 hours after injury. Results: Treatment with MSCs attenuated lung injury in ALI mice by decreasing protein level and neutrophil recruitment into the BALF and improving the histologic change. MSCs also decreased the protein levels of proinflammatory cytokines including IL-1β, IL-6, and TNF-α, but had little effect on the protein expression of PCNA, caspase-3, and caspase-9. Conclusions: Intratracheal injection of bone marrow-derived allogenic MSCs attenuates LPSinduced ALI via immunomodulatory effects.
Abstract
Background: Mesenchymal stem cells (MSCs) attenuate injury in various lung injury models through paracrine effects. We hypothesized that intratracheal transplantation of allogenic MSCs could attenuate lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice, mediated by anti-inflammatory responses. Methods: Six-week-old male mice were randomized to either the control or the ALI group. ALI was induced by intratracheal LPS instillation. Four hours after LPS instillation, MSCs or phosphate-buffered saline was randomly intratracheally administered. Neutrophil count and protein concentration in bronchoalveolar lavage fluid (BALF); lung histology; levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and macrophage inflammatory protein-2; and the expression of proliferation cell nuclear antigen (PCNA), caspase-3, and caspase-9 were evaluated at 48 hours after injury. Results: Treatment with MSCs attenuated lung injury in ALI mice by decreasing protein level and neutrophil recruitment into the BALF and improving the histologic change. MSCs also decreased the protein levels of proinflammatory cytokines including IL-1β, IL-6, and TNF-α, but had little effect on the protein expression of PCNA, caspase-3, and caspase-9. Conclusions: Intratracheal injection of bone marrow-derived allogenic MSCs attenuates LPSinduced ALI via immunomodulatory effects.
참고문헌 (34)
- Rubenfeld GD, "Incidence and outcomes of acute lung injury", N Engl J Med, 353, pp.1685~1693 (2005)[DOI]
- Bellani G, "Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries", JAMA, 315, pp.788~800 (2016)[DOI]
- Zambon M, "Mortality rates for patients with acute lung injury", ARDS have decreased over time, 2008, pp.133, 1120~1127
- Amato MB, "Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome", N Engl J Med, 338, pp.347~354 (1998)[DOI]
- Guerin C, "Prone positioning in severe acute respiratory distress syndrome", N Engl J Med, 368, pp.2159~2168 (2013)[DOI]
- Peek GJ, "Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial", Lancet, 374, pp.1351~1363 (2009)[DOI]
- Hudson LD, "Clinical risks for development of the acute respiratory distress syndrome", Am J Respir Crit Care Med, 151, pp.293~301 (1995)[DOI]
- Doyle RL, "Identification of patients with acute lung injury. Predictors of mortality", Am J Respir Crit Care Med, 152, pp.1818~1824 (1995)[DOI]
- Matthay MA, "Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management", Am J Respir Cell Mol Biol, 33, pp.319~327 (2005)[DOI]
- Chollet-Martin S, "Polymorphonuclear neutrophil activation during the acute respiratory distress syndrome", Intensive Care Med, 26, pp.1575~1577 (2000)[DOI]
- Abraham E, "Neutrophils and acute lung injury", Crit Care Med, 31(4 Suppl), pp.S195~S199 (2003)[DOI]
- Stephens KE, "Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs", Am Rev Respir Dis, 138, pp.1300~1307 (1988)[DOI]
- Perkins GD, "In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury", Thorax, 62, pp.36~42 (2007)[DOI]
- Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)[DOI]
- Li TS, "Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-betapreprogrammed bone marrow stem cells", Circulation, 111, pp.2438~2445 (2005)[DOI]
- Miyahara Y, "Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction", Nat Med, 12, pp.459~465 (2006)[DOI]
- Lee RH, "Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6", Cell Stem Cell, 5, pp.54~63 (2009)[DOI]
- Parekkadan B, "Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure", PLoS One, 2, pp.e941~ (2007)[DOI]
- Mei SH, "Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis", Am J Respir Crit Care Med, 182, pp.1047~1057 (2010)[DOI]
- Ortiz LA, "Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects", Proc Natl Acad Sci U S A, 100, pp.8407~8411 (2003)[DOI]
- Rojas M, "Endotoxininduced lung injury in mice: structural, functional, and biochemical responses", Am J Physiol Lung Cell Mol Physiol, 288, pp.L333~L341 (2005)[DOI]
- Gupta N, "Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxininduced acute lung injury in mice", J Immunol, 179, pp.1855~1863 (2007)[DOI]
- van Helden HP, "Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome", Exp Lung Res, 23, pp.297~316 (1997)[DOI]
- Kim ES, "Intratracheal transplantation of human umbilical cord bloodderived mesenchymal stem cells attenuates Escherichia coliinduced acute lung injury in mice", Respir Res, 12, pp.108~ (2011)[DOI]
- Dominici M, "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement", Cytotherapy, 8, pp.315~317 (2006)[DOI]
- Everhart MB, "Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury", J Immunol, 176, pp.4995~5005 (2006)[DOI]
- Hong SB, "Induced hypothermia as a new approach to lung rest for the acutely injured lung", Crit Care Med, 33, pp.2049~2055 (2005)[DOI]
- Ware LB, "The acute respiratory distress syndrome", N Engl J Med, 342, pp.1334~1349 (2000)[DOI]
- Pugin J, "Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1", Am J Respir Crit Care Med, 153, pp.1850~1856 (1996)[DOI]
- Koh Y, "Effects of heat pretreatment on histopathology, cytokine production, and surfactant in endotoxin-induced acute lung injury", Inflammation, 25, pp.187~196 (2001)[DOI]
- Schutte H, "Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema", Eur Respir J, 9, pp.1858~1867 (1996)[DOI]
- Suter PM, "High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis", Am Rev Respir Dis, 145, pp.1016~1022 (1992)[DOI]
- Koh Y, "Cytokine-induced neutrophil chemoattractant is necessary for interleukin-1-induced lung leak in rats", J Appl Physiol, 79, pp.472~478 (1995)[DOI]
- Kawamura H, "Extracellular ATP-stimulated macrophages produce macrophage inflammatory protein-2 which is important for neutrophil migration", Immunology, 136, pp.448~458 (2012)[DOI]
